| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6192400 | Journal of Thoracic Oncology | 2016 | 10 Pages |
Abstract
Diverse targetable METex14 alterations were identified in patients with NSCLC across age groups, including elderly patients, and in all major NSCLC histologic subtypes with an overall frequency of 2.7%. These findings support the use of hybrid capture-based molecular profiling across NSCLC subtypes to identify patients who will potentially benefit from MET TKIs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alexa B. PhD, Garrett M. PhD, James MD, Zachary R. BSc, Mark PhD, Rachel L. PhD, Balazs MD, Jonathan MD, Patrick MD, Kurt MD, Nir MD, PhD, Gregory P. MD, Jeffrey S. MD, Philip J. PhD, Vincent A. MD, Siraj M. MD, PhD, Sai-Hong Ignatius MD, PhD,